Gut microbiome stool test

For recording and assessing the intestinal microbiome of the gut

The intestinal microbiome refers to the totality of all microorganisms that colonise the intestine. A balanced ratio of intestinal bacteria is essential for human health. This is because, as numerous studies have shown, an imbalance in the gut microbiome is associated with various diseases. These include metabolic syndrome, diabetes, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, irritable bowel syndrome, bowel cancer, calcium oxalate urinary stones, cardiovascular diseases, rheumatoid arthritis and neurological disorders.

The so-called next-generation sequencing method has so far only been used in a scientific context to recognise imbalances in the intestinal flora. In contrast to conventional stool diagnostics, it not only covers a limited range of intestinal bacteria, but also the molecular genetic analysis of the entire bacterial intestinal microbiome. In addition, the effects of the individual, highly complex microbiota on colonisation resistance, digestive processes, absorption of nutrients and vitamins as well as on immunity can be assessed more precisely.

The analysis even detects anaerobic bacteria that cannot be cultured. The standard of microbiological stool diagnostics in the 20th century was mainly based on culture, culture media and subsequent enzymatic differentiation. However, very few of the anaerobic bacteria (approx. 99% of intestinal bacteria) grow using cultural methods. In recent years, there has been a rapid development in examination methods. In modern laboratories, the identification of bacteria from the plant on culture media is now largely carried out using mass spectrometry (MALDI-TOF = Matrix Assisted Laser Desorption Ionisation-Time of Flight) or directly from the submitted material using molecular biological methods (PCR = Polymerase Chain Reaction). However, the disadvantage is that PCR is a very selective and cost-intensive technology.

The microbiome data and its expertise can be updated and expanded at regular intervals in the future so that new findings are reflected in the results.

The molecular genetic analysis includes

• Analysing the biodiversity of the intestinal microbiome (diversity)
• Statement on the bacterial dysbiosis
• Determination of the enterotype
• Frequency distribution of the most important bacterial strains>
• Determination of the Firmicutes/Bacteroidetes ratio
• Assessment of the mucosaprotective flora
• Analysis of risk factors for dysbiosis-associated diseases

The test kit includes:

• 1 instruction for sample collection
• 1 set of instructions for requesting results
• 1 sample receipt
• 1 guarantee certificate
• 1 sample container incl. label in shipping container
• 1 microbiome sample tube with label in shipping container
• 1 stool catcher
• 1 shipping container
• 1 envelope

How does the ordering process work?

The link"To article" will take you to the manufacturer's website where you can purchase the product. After your order, Medivere will send you the desired test pack with detailed instructions. You place your sample in a tube and send it in a prepared envelope to Medivere's partner laboratory, GANZIMMUN DIAGNOSTICS AG. You will receive a report with the evaluation of your profile after approx. 14 working days.